ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Co-stimulation"

  • 2020 American Transplant Congress

    Comparison of Reduced-Dose and Labeled-Dose Belatacept Conversion with Immediate or Early Tacrolimus Withdrawal in Kidney Transplant Recipients without Maintenance Corticosteroids

    H. Kuzaro1, A. R. Shields2, M. Cuffy2, E. S. Woodle1, K. Pembaur2, S. Safdar2, S. Huang2, G. Krisko2, S. Raabe2, R. Parks2, J. Kremer2

    1U Cincinnati, Cincinnati, OH, 2The Christ Hospital, Cincinnati, OH

    *Purpose: A primary reason for conversion from tacrolimus (TAC) to belatacept (BELA) is to avoid nephrotoxicity. Previous published experiences with BELA-conversion regimens have shown increased…
  • 2020 American Transplant Congress

    Altering Homeostatic Repopulation with Thymic Irradiation and Donor Mesenchymal Stem Cell Infusions in a Nonhuman Primate Model

    R. Schmitz, M. S. Mulvihill, Z. W. Fitch, T. How, F. Leopardi, A. D. Kirk

    Department of Surgery, Duke University Medical Center, Durham, NC

    *Purpose: Lymphocyte depletion and subsequent homeostatic repopulation present opportunities to shape the alloreactive immune repertoire to favor tolerance. We tested if the addition of thymic…
  • 2020 American Transplant Congress

    Selective Dual Co-Stimulatory Blockade of CD28/CD80-86 and PD1-PL2 with a Novel Recombinant Bi-Specific Fusion Protein (Hybri-2) Promotes Successful Humoral Desensitization in a Stringent Sensitized Rat Model

    A. Torija, E. Crespo, M. Jarque, N. Bolaños, M. Meneghini, A. Favà, J. Torras, J. Grinyo, O. Bestard

    Kidney Transplantation Unit, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

    *Purpose: Humoral Alloimmune memory is a main barrier for successful kidney transplantation and is orchestrated by a compartmentalized cellular immune response driven by bone-marrow LLPCs…
  • 2020 American Transplant Congress

    7-Years Retrospective Cohort of CNI to Belatacept Conversion

    A. Morel1, C. Dudreuilh1, A. Moktefi2, D. Kheav3, D. Mokrani1, K. El Sakhawi1, C. Champy4, P. Rémy1, P. Grimbert1, M. Matignon1

    1Nephrology, APHP Henri Mondor, Créteil, France, 2Anatomopathology, APHP Henri Mondor, Créteil, France, 3Immunology, APHP Saint Louis, Paris, France, 4Urology, APHP Henri Mondor, Créteil, France

    *Purpose: Analyze the long-term evolution after calcineurin inhibitors (CNIs) to Belatacept conversion in kidney allograft recipients.*Methods: In this single-center retrospective study, we collected all patients…
  • 2020 American Transplant Congress

    CMV, EBV and BKV Viremia Rate Varied Depending on the Timing of Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression and HLA-Sensitization (HS) Status in Kidney Transplant Patients (KTx Pts)

    B. Shin, N. Ammerman, A. Vo, S. C. Jordan, M. Toyoda, S. Sethi

    Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: Viral infections (VI) represent significant morbidity and mortality factors for KTx Pts. We previously showed more VI in BLT-treated Pts compared with CNI Pts…
  • 2020 American Transplant Congress

    Mitochondrion-Endothelial Interaction Generates Danger Signal in Promoting Costimulation-Resistant T Cell-Mediated Allograft Rejection

    S. Li1, M. Song1, Q. Li2, A. Kirk1, H. Xu1

    1Surgery, Duke University, Durham, NC, 2Immunology, Duke University, Durham, NC

    *Purpose: Endothelial cells (ECs) play a critical role in allorecognition, presentation, and costimulation for initiation of alloimmune rejection. The objective of this study was to…
  • 2020 American Transplant Congress

    Splenectomy Impedes B Cell Infiltration Associated with Rejection of Neonatal Porcine Islet Xenografts

    Z. W. Fitch, M. Song, R. Schmitz, F. Leopardi, M. Ribeiro, A. Miller, G. Devi, B. Collins, X. Luo, A. D. Kirk

    Duke University, Durham, NC

    *Purpose: Xenotransplantation has historically been frustrated by antibody-mediated rejection. Splenectomy has shown efficacy in mediating humoral immunity. We hypothesized that adding splenectomy to a clinically…
  • 2020 American Transplant Congress

    Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression During the First Year Post-Transplant (<1yr Tx) Increases Risk for CMV Infection Through Inhibition of Anti-CMV Humoral Immunity

    B. Shin, N. Ammerman, S. Sethi, A. Vo, S. C. Jordan, M. Toyoda

    Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: We have shown a higer CMV infection rate in kidney Tx patients (KTx Pts) who were converted to BLT 1yr post-Tx. Viral infections are…
  • 2019 American Transplant Congress

    Belatacept Based Simultaneous Calcineurin Inhibitor Avoidance/Early Corticosteroid Withdrawal is Associated with Low New Onset Diabetes Risk

    A. R. Shields1, P. West-Thielke2, E. S. Woodle1, D. B. Kaufman3, J. Lipscomb4, J. P. Leone5, A. Wiseman6, E. King4, A. J. Matas7, R. R. Alloway for the BEST Study Group4

    1Transplant Surgery, U of Cincinnati, Cincinnati, OH, 2UIC, Chicago, IL, 3Transplant Surgery, U of Wisconsin, Madison, WI, 4U of Cincinnati, Cincinnati, OH, 5Tampa General, Tampa, FL, 6U of Colorado, Denver, CO, 7U Minnesota, Minneapolis, MN

    *Purpose: Calcineurin inhibitor (CNI) and/or corticosteroid (CCS) therapy are associated with significant risk of new onset diabetes after transplantation (NODAT). An important consideration for simultaneous…
  • 2019 American Transplant Congress

    CNI-Free Therapy with Iscalimab (anti-CD40 mAb) Preserves Allograft Histology Compared to Standard of Care after Kidney Transplantation

    E. Farkash1, A. Naik1, H. Tedesco-Silva2, B. Nashan3, O. Witzke4, M. van den Hoogen5, S. Berger6, D. M. Cibrik7, S. Mulgaonkar8, D. B. Leeser9, R. Alloway10, A. Patel11, J. Pratchke12, C. Sommerer13, A. Wiseman14, A. Van Zuilen15, U. Laessing16, J. Rush16, B. Haraldsson16

    1Univ of Michigan, Ann Arbor, MI, 2Hospital do Rim, São Paulo, Brazil, 3Univ. Hamburg, Hamburg, Germany, 4Univ Essen, Essen, Germany, 5Erasmus MC, Rotterdam, Netherlands, 6UMC Groningen, Gröningen, Netherlands, 7Univ of Kansas, Kansas City, KS, 8Saint Barnabas MC, Livingston, NJ, 9East Carolina Univ, Greenville, NC, 10Univ of Cincinnati, Cincinnati, OH, 11Henry Ford Hosp, Detroit, MI, 12Charité Univ, Berlin, Germany, 13Univ Heidelberg, Heidelberg, Germany, 14Univ of Colorado SM, Denver, CO, 15Univ MC, Utrecht, Netherlands, 16Novartis, Basel, Switzerland

    *Purpose: To assess if calcineurin (CNI)-free therapy with iscalimab preserves the quality of transplanted kidney grafts.*Methods: Iscalimab (CFZ533) is a new, fully human, Fc-silenced, non-depleting,…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 30
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences